| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Candidates Quality Significance (-10lgP) m/z RT range z Avg. Area Sample Profile Group Profile RT mean Start End Used PTM
K.LTGMAFR.V 4.46 0.97 398.2164 58.80 - 63.58 2 9.2E5 61.41 256 262 N
K.VIPELNGK.L 4.70 1.74 435.2626 51.11 - 55.88 2 6.7E5 53.76 248 255 N
R.GASQNIIPASTGAAK.A 5.07 2.36 693.3793 49.37 - 53.98 2 6E5 52.09 229 243 N
R.VPTPNVSVVDLTVR.L 3.16 12.17 748.4341 102.57 - 105.09 2 3.1E5 103.80 263 276 N
K.LTGMAFR.V 3.05 3.57 795.4254 58.83 - 63.55 1 7E4 61.42 256 262 N
R.GASQNIIPASTGAAK.A 2.99 2.56 462.5890 49.16 - 54.36 3 6.5E4 52.08 229 243 N
R.VPTPNVSVVDLTVR.L 2.29 3.49 499.2913 102.53 - 105.19 3 6.5E4 103.81 263 276 N
K.VGINGFGR.I 1.32 0.26 410.2292 57.37 - 61.83 2 5.5E4 60.11 34 41 N
K.L(+43.01)TGMAFR.V 2.26 2.85 419.7193 102.00 - 105.60 2 5.2E4 103.58 256 262 N Carbamylation
F.RVPTPNVSVVDLTVR.L 1.39 1.10 551.3276 93.29 - 98.34 3 4.9E4 95.46 262 276 N
H.SSIFDAGAGIALNDHFVK.L 0.53 0.60 621.3209 117.15 - 121.30 3 4.6E4 118.47 320 337 N
R.LEKPAKYDDIKK.V 1.46 3.98 483.2810 30.82 - 34.66 3 3.6E4 32.57 277 288 N
R.VIISAPSADAPMFVMGVNHEK.Y Y 1.45 0.30 738.3809 112.27 - 114.75 3 2.9E4 113.69 147 167 Y
K.LTGMAFR.V 1.75 2.79 398.2195 49.85 - 54.26 2 2.8E4 52.49 256 262 N
K.VVSNASC(-1.01)TTNC(-1.01)LAPLAK.V Y 1.59 2.94 845.4211 62.54 - 66.23 2 2.7E4 64.68 174 190 Y Half of a disulfide bridge
R.LEKPAKYDDIKK.V 0.61 3.93 362.7134 30.75 - 34.56 4 2.3E4 33.16 277 288 N
K.VVSNASCTTNCLAPLAK.V Y 1.60 2.22 846.4339 75.45 - 78.58 2 1.8E4 76.96 174 190 Y
K.LVSWYDNEFAYSNR.V Y 1.42 1.43 882.4151 104.98 - 107.96 2 1.7E4 106.21 338 351 N
E.YMVYMFK.Y 1.04 1.15 491.2371 94.52 - 97.93 2 1.6E4 96.81 70 76 N
K.YDDIK.K 0.47 0.48 327.1642 28.73 - 31.06 2 1.5E4 30.35 283 287 N
R.VIISAPSADAPMFVMGVNHEKYDK.S Y 0.98 0.26 655.5860 106.96 - 109.13 4 1.3E4 108.18 147 170 N
K.VVSNASCTTNCLAPLAK.V Y 1.34 2.30 846.4321 81.64 - 84.56 2 1.2E4 83.07 174 190 N
K.VVSNASC(+57.02)TTNCLAPLAK.V Y 0.96 3.14 874.9399 69.40 - 72.77 2 1.2E4 71.30 174 190 N Carbamidomethylation
K.LVSWYDNEFAYSNR.V Y 0.92 0.98 588.6129 104.95 - 107.27 3 1E4 106.16 338 351 N
Y.VVESTGVFTTIEK.A 0.85 1.05 705.3848 82.42 - 83.92 2 1E4 83.15 123 135 N
H.SSIFDAGAGIALNDHFVK.L 0.06 5.42 621.3273 117.72 - 121.30 3 9.7E3 119.33 320 337 N
R.LEKPAKYDDIKK.V 0.59 2.06 724.4157 31.06 - 34.76 2 9.4E3 32.75 277 288 N
K.VVSNASCTTNC(+57.02)LAPLAK.V Y 0.62 1.62 874.9406 64.46 - 69.18 2 8.6E3 66.90 174 190 N Carbamidomethylation
K.ITIFHER.D Y 2.15 3.48 305.8418 51.60 - 56.35 3 8.3E3 54.63 102 108 N
H.SSIFDAGAGIALNDHFVK.L 0.65 1.37 931.4782 117.95 - 121.45 2 8.1E3 118.85 320 337 N
K.V(+43.01)IPELNGK.L 1.36 1.71 456.7671 95.49 - 98.67 2 7.7E3 97.27 248 255 N Carbamylation
K.VVSNASC(+57.02)TTNC(+57.02)LAPLAK.V Y 0.59 2.78 903.4536 59.74 - 63.41 2 6.7E3 62.12 174 190 N Carbamidomethylation
D.APMFVMGVNHEK.Y 1.08 0.08 453.8937 68.76 - 73.14 3 6.7E3 71.25 156 167 N
K.VVSNASC(+57.02)TTNCLAPLAK.V Y 0.71 0.07 874.9434 75.83 - 78.70 2 6.4E3 77.26 174 190 N Carbamidomethylation
K.WGDAGAQYVVESTGVFTTIEK.A Y 0.07 1.94 753.3829 128.63 - 131.50 3 4.7E3 129.56 115 135 N
R.LEKPAKYDDIK.K 0.37 7.06 660.3708 35.74 - 38.87 2 3.2E3 37.75 277 287 N
K.VVSNASCTTNCLAPLAK.V Y 0.21 1.62 564.6236 76.56 - 78.23 3 2.7E3 77.41 174 190 N
total 37 peptides